A team of researchers used machine learning to help develop a model for predicting surgical critical care patients’ risk of developing hospital-acquired pressure injuries, according to a study published in the American Journal of Critical Care.

ScieGen Pharmaceuticals has issued a recall of the blood pressure drug irbesartan after lab testing revealed a carcinogenic impurity, the FDA announced in a MedWatch Safety Alert.

A Stanford- and Apple-led atrial fibrillation study of more than 400,000 U.S. residents—the largest AFib screening effort to date—has entered its final phase of data collection, the company announced Nov. 1. The trial is expected to wrap up early next year.

A hospital IT worker’s Reddit post recently grabbed the attention of the medical imaging community when he discovered a newly installed MRI machine appeared to disable every Apple device in the hospital, according to a report published Oct. 30 by Motherboard.com.

The American Thoracic Society (ATS) and the American Lung Association’s LUNG FORCE initiative have teamed up to create a new website and online toolkit designed to help healthcare institutions implement and operate lung cancer screening programs.

The FDA will allow genetic testing company 23andMe to market personal genome reports as a direct-to-consumer test of a person’s ability to metabolize some medications to help inform discussions with healthcare providers.

Radiologist Timothy Mosher, MD, has developed a first-of-its-kind medical school course that seeks to pinpoint “systemic causes of misdiagnosis” and identify ways of preventing such cases.

A new breast imaging technique uses MR fingerprinting for the volumetric quantification of T1 and T2 relaxation times for breast tissue, according to new research published in Radiology.

DANVERS, Mass., Nov. 01, 2018 — Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart recovery and support technologies, today reported second quarter fiscal 2019 revenue of $181.8 million, an increase of 37% compared to revenue of $132.8 million for the same period of fiscal 2018.

A research team led by Bharti Khurana, MD, of the department of radiology at Brigham and Women’s Hospital in Boston, is working to create a program that can identify signs of intimate partner violence (IPV) in imaging results.